证券代码：300405 证券简称：科隆股份 公告编号：2025-007 辽宁科隆精细化工股份有限公司 第六届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述和重大遗漏。 辽宁科隆精细化工股份有限公司（以下简称"公司"）第六届监事会第二次 会议的通知已于 2025 年 4 月 14 日送达各位监事，并于 2025 年 4 月 24 日在公司 二楼会议室以现场会议方式召开。应到监事 5 人，实到监事 5 人。会议召开及表 决符合《公司法》及《公司章程》的有关规定，会议合法有效。 会议由监事会主席刘会军主持，与会监事审议有关议案，并依照公司章程及 相关法律法规进行认真审议，审议通过如下决议： 一、审议通过了《2024 年度监事会工作报告》，其中同意 5 票，反对 0 票， 弃权 0 票。 详情内容请见公司于同日在中国证监会指定的信息披露网站巨潮资讯网刊 登的《2024 年度监事会工作报告》。 该项议案尚需提交 2024 年年度股东大会审议。 二、审议通过了《2024 年年度报告及摘要》，其中同意 5 票，反对 0 票， 弃权 0 票。 经审核，监事会认为 ...

辽宁科隆精细化工股份有限公司 监事会关于内部控制自我评价报告的审核意见 辽宁科隆精细化工股份有限公司（以下简称"公司"）监事会根据《公司法》、 《深圳证券交易所上市公司内部控制指引》、《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作》》《上市公司治理准则》等相关法律、 法规的规定，对相关事项作出以下核实意见： 监事会关于公司《2024 年内部控制自我评价报告》的核实意见 依据深交所相关法律、法规的相关要求，公司董事会对公司 2024 年度内部 控制情况进行了全面深入的检查，在查阅了公司的各项内部控制制度，了解公司 有关部门在内部控制实施工作的基础上，对公司的内部控制情况进行了评价，并 出具了公司《2024 年度内部控制自我评价报告》。 辽宁科隆精细化工股份有限公司 监事会关于相关事项的审核意见 （本页为签字页） 我们通过调查并对《2024 年度内部控制自我评价报告》审议后，认为： 1、公司内部控制制度符合我国有关法规和证券监管部门的要求，符合管理 要求的内部组织结构，也适合目前公司生产经营实际情况需要。 2、公司的组织架构和内部控制措施对企业管理各个过程、各个环节的控制 发挥了较好的 ...

证券代码：300405 证券简称：科隆股份 公告编号：2025-006 辽宁科隆精细化工股份有限公司 第六届董事会第二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、董事会会议召开情况 本次会议审议并通过如下决议： 1、审议通过《2024 年度总经理工作报告》（议案 1） 1、发出会议通知的时间和方式：2025 年 4 月 14 日以书面、邮件方式通知 各位董事； 2、会议召开时间：2025 年 4 月 24 日上午； 3、会议召开地点：公司二楼会议室； 4、会议召开方式：现场会议方式召开； 5、会议出席情况：本次会议应到董事 9 人，实到董事 9 人，本公司监事、 高级管理人员列席会议。 6、会议主持人：董事长姜艳女士； 7、召开情况合法、合规、合章程性说明：会议召开及表决符合《公司法》 及《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 辽宁科隆精细化工股份有限公司（以下简称"本公司"或"公司"）于 2025 年 4 月 24 日召开第六届董事会第二次会议。 该项议案无需提交股东大会审议。 表决结果：9 票同意，0 票反对， ...

证券代码：300405 证券简称：科隆股份 公告编号：2025-012 辽宁科隆精细化工股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 重要内容提示： 1、公司第六届董事会第二次会议审议通过了《2024 年度利润分配的预案》： 2024 年度不派发现金红利，不送红股，不以公积金转增股本。 2、公司不触及《深圳证券交易所创业板股票上市规则》第 9.4 条规定的可 能被实施其他风险警示的情形。 辽宁科隆精细化工股份有限公司（以下简称"公司"）第六届董事会第二次 会议审议通过了《2024 年度利润分配的预案》，为了充分保护广大投资者的利 益，现将有关情况公告如下： 一、利润分配基本情况 经大信会计师事务所（特殊普通合伙）审计，公司 2024 年度合并报表归属 于母公司股东的净利润为-49,832,853.83 元，其中母公司实现净利润为 2,175,986.52 元。根据《公司章程》等相关法律法规的规定，截至 2024 年 12 月 31 日公司母公司累计未分配利润-31,777,898.52 元，公司合并报表未分 ...

关于作废 2023 年股权激励计划部分已授予但尚未归属的限 制性股票的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述和重大遗漏。 辽宁科隆精细化工股份有限公司（以下简称"公司"或"科隆股份"）于2025 年4月24日召开第六届董事会第二次会议和第六届监事会第二次会议 ，审议通过 了《关于作废2023年股权激励计划部分已授予但尚未归属的限制性股票的议案》， 因激励对象离职、公司2024年度业绩考核未达标引起的112.25万股第二类限制性 股票不满足归属条件，不予归属，根据《上市公司股权激励管理办法》《2023 年股权激励计划（草案）》等相关规定，公司决定将其作废。现将相关事项说明 如下： 一、2023年股权激励计划已履行的相关审批程序 证券代码：300405 证券简称：科隆股份 公告编号：2025-017 辽宁科隆精细化工股份有限公司 （一）2023 年 4 月 26 日，公司召开第五届董事会第九次会议、第五届监事 会第六次会议，审议通过了《关于公司<2023 年股权激励计划（草案）>及其摘 要的议案》《关于公司<2023 年股权激励计划实施考核管理办法>的议案》，公 ...

北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 8/9/11/F, Emperor Group Centre, No.12D, Jianwai Avenue, Chaoyang District, Beijing, 100022, P.R.China 电话/Tel.: 010-50867666 传真/Fax: 010-56916450 网址/Website: www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 北京市康达律师事务所 关于辽宁科隆精细化工股份有限公司 2023 年股权激励计划部分已授予但尚未归属的限制性股票作废的 法律意见书 康达法意字【2025】第 0173 号 二零二五年四月 法律意见书 释 义 在本《法律意见书》中，除非文义另有所指，下列词语或简称具有下述涵义： | 简称 | 含义 | | --- | --- | | 本所 | 北京市康达律师事务所 | | 科隆股份/上市公司/公司 | 辽宁科隆精细化工股份有限公司 | | 本次激 ...

不分配不转增 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.1752 | -0.3480 | 49.66 | -0.4106 | | 每股净资产（元） | 1.57 | 1.79 | -12.29 | 2.21 | | 每股公积金(元) | 1.17 | 1.17 | 0 | 1.24 | | 每股未分配利润(元) | -0.70 | -0.52 | -34.62 | -0.17 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 6.32 | 5.58 | 13.26 | 7.81 | | 净利润(亿元) | -0.5 | -1 | 50 | -1.19 | | 净资产收益率(%) | -10.32 | -17.01 | 39.33 | -16.80 | | 名称 持有数量(万股) | | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | ...

Financial Performance - The company reported a basic earnings per share of -0.0544 yuan for Q1 2025, a decrease of 69.47% compared to -0.0321 yuan in Q1 2024 [1] - The net profit for Q1 2025 was -0.15 billion yuan, reflecting a decline of 66.67% from -0.09 billion yuan in Q1 2024 [1] - Operating revenue decreased by 34.53% to 0.91 billion yuan in Q1 2025, down from 1.39 billion yuan in Q1 2024 [1] - The return on equity was -3.52% in Q1 2025, a significant drop of 94.48% compared to -1.81% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 50.373 million shares, accounting for 23.02% of the circulating shares, with a decrease of 4.8299 million shares from the previous period [1] - Notable shareholders include Jiang Yan with 21.3877 million shares (9.78%) and the single asset management plan with 14.3306 million shares (6.55%), both remaining unchanged [2] - New entrants among the top shareholders include Wang Qiyu with 2.1514 million shares (0.98%) and China Minsheng Bank's fund with 1.8425 million shares (0.84%) [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [4]

Revenue and Profitability - The company's revenue for Q1 2025 was ¥90,541,692.87, representing a decrease of 34.85% compared to ¥138,973,187.50 in the same period last year[4] - Total operating revenue decreased to ¥90,695,619.83 from ¥139,112,944.92, representing a decline of approximately 34.8% year-over-year[21] - Net profit for the period was a loss of ¥15,462,907.43, compared to a loss of ¥9,108,412.55 in the previous period, indicating a worsening of approximately 70.5%[22] - The net loss attributable to shareholders was ¥15,477,219.17, a decline of 71.44% from a loss of ¥9,027,818.26 in the previous year[4] - Basic and diluted earnings per share were both -¥0.0544, down 69.47% from -¥0.0321 in the same quarter last year[4] - Basic and diluted earnings per share were both -0.0544, compared to -0.0321 in the previous period[23] Cash Flow and Liquidity - The net cash flow from operating activities was -¥48,628,760.28, which is a 38.23% increase in cash outflow compared to -¥35,180,642.88 in the prior year[4] - Cash inflow from operating activities was ¥96,403,131.92, down from ¥156,649,888.71, a decrease of about 38.4% year-over-year[25] - The total cash and cash equivalents at the end of the period stood at 33,460,537.93, down from 76,838,652.12 in the previous period, showing a decrease in liquidity[26] - The company reported a total cash outflow from operating activities of 145,031,892.20, compared to 191,830,531.59 in the previous period, suggesting reduced operational expenses[26] - Net cash flow from operating activities was -48,628,760.28, compared to -35,180,642.88 in the previous period, indicating a decline in operational cash generation[26] - Cash paid for debt repayment was 297,600,000.00, compared to 372,242,857.14 in the previous period, reflecting a reduction in debt servicing[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,037,507,450.33, a decrease of 1.22% from ¥1,050,287,904.79 at the end of the previous year[4] - Current assets decreased to CNY 605,484,354.47 from CNY 613,619,864.77, primarily due to a reduction in cash and accounts receivable[17][18] - Total liabilities increased to ¥592,499,173.29 from ¥589,794,747.54, a slight increase of about 0.3%[19] - Total equity decreased to ¥445,008,277.04 from ¥460,493,157.25, a decline of approximately 3.4%[19] - The company’s non-current assets totaled CNY 432,023,095.86, slightly down from CNY 436,668,040.02, indicating a stable asset base[17] Inventory and Contract Liabilities - The company's inventory increased by 36.56% to ¥179,967,968.82, attributed to preparations for sales in the second quarter[7] - The company's contract liabilities rose by 91.71% to ¥9,140,064.91, indicating an increase in advance payments received[7] - Accounts receivable decreased by 17.2% to CNY 248,333,064.62 from CNY 300,161,245.08[17] - Inventory increased by 36.6% to CNY 179,967,968.82 from CNY 131,786,873.27, indicating potential growth in production or sales[18] Legal and Regulatory Matters - The company is currently involved in a legal dispute regarding a liability claim, which may impact future operations[16] - The company plans to actively defend its legal rights in the ongoing court case, which may affect its strategic direction[16] Other Financial Metrics - Non-operating income increased by 82.43% to ¥163,361.19, primarily due to a reduction in fines received compared to the previous year[9] - The company reported a total non-recurring gains and losses of ¥1,823,871.96, which includes government subsidies and asset disposal gains[5] - The company reported a significant increase in financial expenses, totaling ¥4,863,796.08, compared to ¥6,713,794.07 in the previous period, indicating a decrease of about 27.5%[22] - Deferred income decreased to ¥18,648,936.01 from ¥19,060,212.10, a reduction of approximately 2.2% year-over-year[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,045, with the largest shareholder holding 30.08% of the shares[11] - The total number of restricted shares at the end of the period was 65,589,992, with no new restricted shares added during the current period[14][15] Accounting and Reporting - The company did not apply the new accounting standards for the current reporting period[27] - The first quarter report was not audited, which may affect the reliability of the financial data presented[28]

Financial Performance - The company's operating revenue for 2024 was CNY 631,834,145.97, representing a 13.19% increase compared to CNY 558,195,980.29 in 2023[20]. - The net profit attributable to shareholders improved to -CNY 49,832,853.83 in 2024, a 50.28% reduction in losses from -CNY 100,230,449.54 in 2023[20]. - The net cash flow from operating activities increased significantly by 197.26% to CNY 31,153,859.20 in 2024, compared to CNY 10,480,417.49 in 2023[20]. - The total assets decreased by 17.10% to CNY 1,050,287,904.79 at the end of 2024, down from CNY 1,266,978,860.14 at the end of 2023[20]. - The company's basic earnings per share improved to -CNY 0.1752 in 2024, a 49.66% improvement from -CNY 0.3480 in 2023[20]. - The company's net assets attributable to shareholders decreased by 11.85% to CNY 447,766,836.44 at the end of 2024, compared to CNY 507,982,095.03 at the end of 2023[20]. - The weighted average return on equity improved to -10.32% in 2024 from -17.01% in 2023, indicating a positive trend despite ongoing losses[20]. - The company reported a total of CNY 19,209,446.37 in non-recurring gains and losses for 2024, compared to CNY 14,442,595.58 in 2023[26]. Market and Industry Trends - The construction industry demand has decreased, with a reported 18.3% decline in sales amount for the top 100 real estate companies in 2024 compared to 2023[29]. - The production of key products in the concrete and cement products industry continued to decline, with an 11.3% decrease in ready-mixed concrete production year-on-year from January to August 2024[29]. - The carboxylic acid superplasticizer market benefits from the promotion of new construction technologies, such as ultra-high-performance concrete applications, and increased international market demand[30]. - The demand for phenolic ether products in China has significantly increased over the past three years, driven by the needs of downstream industries like chemicals, pharmaceuticals, and coatings[31]. - The market for hydroxyethyl acrylate is expected to grow further due to rapid development in the construction and automotive industries, driven by urbanization and economic growth[31]. Research and Development - The company has a strong R&D capability, collaborating with institutions like the Chinese Academy of Sciences and Shenyang Chemical Research Institute[39]. - The company has developed new polyether monomers that enhance product performance, particularly in high-silt concrete applications, showcasing strong adaptability to various cement types[34]. - The company’s surface active agents are produced using proprietary technology, targeting specific types of surfactants for various industrial applications[35]. - The company’s UV-curable polyether is in trial production, with a focus on achieving low potassium and sodium ion content, enhancing application effects[35]. - The company focuses on the fine chemical field, upgrading existing products and increasing international market sales[45]. - The company has a strong talent strategy, with a team that includes 1 PhD and 8 master's degree holders, enhancing its R&D capabilities in fine chemicals[57]. - R&D investment amounted to ¥21,350,734.89 in 2024, representing 3.38% of operating revenue, an increase from 3.17% in 2023[72]. Corporate Governance - The company adheres to legal regulations and maintains a transparent governance structure, ensuring equal rights for all shareholders[106]. - The company has successfully held one annual and one extraordinary shareholders' meeting, complying with all procedural requirements[107]. - The company held 7 board meetings during the reporting period, complying with all regulations and promptly disclosing the results[108]. - The independent directors actively participated in meetings and conducted on-site investigations to ensure compliance and protect shareholder interests[109]. - The company has established a transparent performance evaluation and incentive mechanism for directors, supervisors, and senior management[109]. - The company respects the rights of stakeholders and promotes balanced interests among shareholders, employees, and society[109]. - The company has established a clear remuneration decision-making process based on operational performance and budget execution[128]. Environmental Responsibility - The company is classified as a key pollutant discharge unit by the environmental protection department[151]. - The company has obtained environmental impact assessment approvals for multiple projects, including a 5,000-ton thermoplastic polyester elastomer project and a 100,000-ton high-performance concrete polycarboxylic acid water reducer project[152]. - The company has been compliant with various environmental protection laws and regulations, including the Environmental Protection Law and the Air Pollution Prevention and Control Law[151]. - The company has implemented strategies for environmental credit evaluation and public participation in environmental protection[152]. - The company has established a framework for emergency management of environmental incidents as per the relevant regulations[152]. Strategic Plans and Investments - The company plans to invest in a graphene coating project with an annual production capacity of 5,000 tons, expected to be completed by 2025[47]. - The company aims to enhance its product portfolio and management capabilities to improve profitability, focusing on fine chemical fields and new business development[92]. - The company plans to invest in and acquire emerging businesses, particularly in microelectronics, new energy, and new chemical materials, to rapidly expand assets and scale[97]. - The company emphasizes a dual development strategy of "internal growth and external expansion" to achieve rapid asset and scale growth through mergers and acquisitions[92]. - The company plans to enhance its production scale and expand product applications to increase market share and product value[94]. Compliance and Risk Management - The company has established a robust internal control system to ensure the reliability of financial reporting and operational efficiency[166]. - The company has not faced any administrative or criminal penalties in the last five years, ensuring a clean compliance record[166]. - The company has committed to full cash compensation for any losses incurred by shareholders due to non-compliance with commitments[166]. - The company has ensured that its accounting practices are standardized and that financial results are accurately represented[166]. - The company has committed to avoiding related party transactions unless unavoidable, ensuring fair pricing based on market standards[166]. Shareholder Engagement - The company plans to increase its stock holdings with an investment of no less than RMB 10 million and not exceeding RMB 20 million[118]. - The management team is committed to enhancing shareholder value through strategic stock purchases[118]. - The company’s governance structure does not involve any differential voting rights arrangements[117]. - The company has announced a shareholding increase plan for its directors and senior management[117]. - The company will take responsibility for any losses caused to investors due to violations of commitments[167].